Continence Care: Compare the Trial Wean Off Catheter (TWOC) outcome of Acute Retention of Urine (AROU) patients with and without COVID-19

This abstract has open access
Abstract Description
Abstract ID :
HAC541
Submission Type
Proposed Topic (Most preferred): :
Clinical Safety and Quality Service II (Projects aiming to enhance clinical safety and outcomes, clinical governance / risk management)
Proposed Topic (Second preferred): :
Clinical Safety and Quality Service III (Projects aiming at quality service to patients and their carers)
Authors (including presenting author) :
CM Chan, SWA Wong, YY Chung, YLE Cheng
Affiliation :
(1)Continence Nurse Clinic (2) Department of Medicine & Geriatrics, United Christian Hospital, KEC, HA
Introduction :
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causing the COVID-19 pandemic since 2019. Some lecture reported that lower urinary tract symptoms (LUTS) and acute retention of urine (AROU) may be one of the early signs and symptoms of COVID-19, especially in elderly patients. In KEC Catheter Care Clinic, there were 65 patients confirmed with COVID-19 presented AROU without other possible underlying causes during the January 2021 to March 2023. Continence nurses should clearly understand the relationship of AROU information and COVID positive patients in order to facilitate early removal of Foley catheter.
Objectives :
To review TWOC data and successfully rate of TWOC result with and without COVID-19
Methodology :
Retrospective study was designed for collecting patient’s data with AROU from January 2021 to March 2023. The dates of developing AROU, residue urine (RU) volume, episodes and outcome of TWOC was reviewed in both COVID-19 positive and negative groups
Result & Outcome :
Total 175 patients’ data were collected, 65 patients (average age 82.5) who were COVID-19 positive with 83.1% developed AROU on admission to Day 5 without other possible underlying causes. The RU was 771ml. The patients underwent average 2.7 times to achieve successful TWOC within 32 days, with successful rate 49.2%. The results compared to 110 patients without COVID with average age 80.9 with underlying cause including constipation and urinary tract infection, with RU 706 ml whom underwent average 2 times of successfully TWOC within 13 days (successful rate 41.6%). Results shown that AROU patients with COVID-19 needed one more attempts of TWOC and longer time (2.5 times) for a successful TWOC compared to non-COVID-19 patients which have similar successful rate. Total 175 patients’ data were collected, 65 patients (average age 82.5) who were COVID-19 positive with 83.1% developed AROU on admission to Day 5 without other possible underlying causes. The RU was 771ml. The patients underwent average 2.7 times to achieve successful TWOC within 32 days, with successful rate 49.2%. The results compared to 110 patients without COVID with average age 80.9 with underlying cause including constipation and urinary tract infection, with RU 706 ml whom underwent average 2 times of successfully TWOC within 13 days (successful rate 41.6%). Results shown that AROU patients with COVID-19 needed one more attempts of TWOC and longer time (2.5 times) for a successful TWOC compared to non-COVID-19 patients which have similar successful rate.
Hospital Authority
17 visits